Down syndrome: is it really characterized by precocious immunosenescence?
- nov 2014
- Esther de Vries
- 1
- 3193
ARTIKEL: Kusters MA, Verstegen RH, de Vries E. Aging Dis. 2011 Dec;2(6):538-45.
Bijlagen
| titel | toegevoegd | door | opties | |
|---|---|---|---|---|
| ad-2-6-538.pdf | nov 2014 |  |
Verken
Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome.
nov 2014ARTIKEL: Kusters MA, Jol-van der Zijde CM, van Tol MJ, Bolz WE, Bok LA, Visser M, de Vries E. Pediatr...
Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.
nov 2014ARTIKEL: Verstegen RH, Kusters MA, Gemen EF, de Vries E. Pediatr Res. 2010 May;67(5):563-9.
Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases.
nov 2014ARTIKEL: Verstegen RH, Borte S, Bok LA, van Zwieten PH, von Döbeln U, Hammarström L, de Vries E. J All...